Interact to see
Advertisement
Advertisement
EOT vs NZF
EOT vs NZF Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
EOT vs. NZF commentary
Jul 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOT is a Buy and NZF is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
NZF has more net assets: 2.4B vs. EOT (274M). NZF has a higher annual dividend yield than EOT: NZF (2.582) vs EOT (2.087). EOT was incepted earlier than NZF: EOT (16 years) vs NZF (24 years). EOT (0.91) has a lower expense ratio than NZF (1.60). EOT has a higher turnover NZF (16.00) vs NZF (16.00).
| EOT | NZF | EOT / NZF | |
| Gain YTD | 2.087 | 2.582 | 81% |
| Net Assets | 274M | 2.4B | 11% |
| Total Expense Ratio | 0.91 | 1.60 | 57% |
| Turnover | 28.00 | 16.00 | 175% |
| Yield | 4.50 | 5.58 | 81% |
| Fund Existence | 16 years | 24 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| EOT | NZF | |
|---|---|---|
| RSI ODDS (%) | 29 days ago 77% | 1 day ago 50% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 84% | 1 day ago 73% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 74% |
| Advances ODDS (%) | 1 day ago 74% | 3 days ago 76% |
| Declines ODDS (%) | N/A | 19 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 77% | 1 day ago 65% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 74% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TRFM | 43.40 | 0.60 | +1.41% |
| AAM Transformers ETF | |||
| USSE | 32.36 | 0.42 | +1.31% |
| Segall Bryant & Hamill Select Equity ETF | |||
| ETW | 8.70 | 0.05 | +0.58% |
| Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
| CNCR | 9.02 | N/A | N/A |
| Range Cancer Therapeutics ETF | |||
| LIAK | 194.65 | N/A | N/A |
| LifeX 2054 Infl-Prt Longevity Inc ETF | |||